284 filings
Page 2 of 15
8-K
xjpck9i qhwcu
28 Jul 22
Departure of Directors or Certain Officers
4:01pm
8-K
0dlzkisxo6
31 May 22
Departure of Directors or Certain Officers
4:01pm
8-K
pnqi6n
5 May 22
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
vksm0p5mn uzenglv
28 Apr 22
Gilead Sciences Announces First Quarter 2022 Financial Results
4:07pm
8-K
7zi5quna8a80rl
7 Mar 22
Regulation FD Disclosure
8:30am
8-K
an1vyj1vkwo5g72k
1 Feb 22
Gilead Sciences Announces Fourth Quarter and Full Year 2021 Financial Results
4:07pm
8-K
sh2fxk
1 Feb 22
Results of Operations and Financial Condition
4:03pm
8-K
xo23hzry cq
6 Jan 22
Departure of Directors or Certain Officers
4:30pm
8-K
9qlhnflaeoevbqc wg
28 Oct 21
Gilead Sciences Announces Third Quarter 2021 Financial Results
4:09pm
8-K
puhsafrt5sn5ptrora
29 Jul 21
Gilead Sciences Announces Second Quarter 2021 Financial Results
4:05pm
8-K
2c06qgf038 h46
14 May 21
Submission of Matters to a Vote of Security Holders
3:04pm
8-K
364t7t52u4
29 Apr 21
Gilead Sciences Announces First Quarter 2021 Financial Results
4:06pm
8-K
vm6pexi7hvrqn ed1y3
4 Feb 21
Gilead Sciences Announces Fourth Quarter and Full Year 2020 Financial Results
4:05pm
8-K
4pz5dtc qb52l3m
11 Jan 21
Gilead Sciences Announces Updated 2020 Guidance
6:04am
8-K
bcda6spix4ndgfi ha
8 Dec 20
Jeffrey a. Bluestone Joins Gilead Sciences’ Board of Directors
4:14pm
8-K
3t2rtw
28 Oct 20
Gilead Sciences Announces Third Quarter 2020 Financial Results
4:09pm
8-K
x620c r5we
23 Oct 20
Completion of Acquisition or Disposition of Assets
5:12pm
8-K
066wqe
22 Oct 20
Anthony Welters Joins Gilead Sciences’ Board of Directors
12:34pm
8-K
ps3djnnd0ool
30 Sep 20
Entry into a Material Definitive Agreement
8:19am
8-K
pul3phxbh2i
29 Sep 20
Entry into a Material Definitive Agreement
4:21pm